Interviews with men with prostate cancer about breast-related treatment side effects
Explores how men with prostate cancer view breast enlargement as a treatment side effect.
Plain-language title generated from the registry record
Registry title: Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Stage 1
Key facts
- Where
- Sydney, AustraliaSee the site
Where in Australia
- Kinghorn Cancer CentreSydney, AustraliaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- St Vincent's Hospital, Sydney
- Trial code
- NCT07552922
- Record updated
- 27 April 2026
- Original description
This study aims to explore the perceptions of men with prostate cancer (PCa) and high-risk biochemical recurrence (BCR) regarding the risk of breast-related side effects, including gynaecomastia, from treatment.Read full original descriptionShow less
Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Qualitative Stage
This study aims to explore the perceptions of men with prostate cancer (PCa) and high-risk biochemical recurrence (BCR) regarding the risk of breast-related side effects, including gynaecomastia, from treatment.
Inclusion: Men with high-risk BCR PCa but no ADT+/-ARPI experience; Men with ADT+/-ARPI experience who have experienced breast-related side effects from this treatment.
Exclusion: Men receiving psychiatric care as a consequence of their prostate cancer diagnosis or treatment thereof.